ULURU Stock Price, News & Analysis (OTCMKTS:ULUR) Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume6,691 shsMarket Capitalization$5.35 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsStock AnalysisChartFinancialsHeadlinesSEC Filings About ULURU Stock (OTCMKTS:ULUR)ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include Aphthasol paste for the treatment of canker sores; OraDisc A for canker sores; and OraDisc B, which is used for the treatment and management of oral pain. ULURU Inc. was founded in 1987 and is based in Addison, Texas.Read More ULUR Stock News HeadlinesNovember 28, 2023 | theguardian.comPat Dodson and other Indigenous politicians back focus on truth-telling after voice referendum failureNovember 22, 2023 | msn.comFormer ranger makes history as first Indigenous director of Kakadu, Uluru and Commonwealth parksDecember 2, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.November 21, 2023 | msn.comNT residents struggling with expensive Christmas airfares as government announces new tourist flights to UluruNovember 20, 2023 | msn.comWA's Wave Rock Weekender music festival slammed by Aboriginal elderNovember 18, 2023 | msn.comTravel 'facts' that are surprisingly NOT trueNovember 16, 2023 | msn.comUluru: The mysterious, magical heart of Australia’s Red CentreNovember 13, 2023 | msn.comExperts struggle to explain these 30 mysterious placesDecember 2, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.November 10, 2023 | msn.comTourists shaken after dramatic Emu Run bus trip between Uluru and Alice SpringsNovember 8, 2023 | msn.comRomantic Fiji getaways, redefined Paris stays, and Uluru adventures in our travel dealsNovember 8, 2023 | msn.comPhotos that prove Australia is the road trip capital of the worldNovember 6, 2023 | afr.comVoice leaders demand Labor deliver Indigenous treatyNovember 6, 2023 | theguardian.com‘The Uluru statement stands’: key yes campaigners to keep working towards Indigenous voiceNovember 1, 2023 | bbc.com'The police were feeding information to the press': The Australian mother wrongly convicted of murderOctober 21, 2023 | thetimes.co.ukWhat I found at Uluru: Australia’s most sacred Aboriginal siteOctober 17, 2023 | msn.comEntire Uluru Statement from the Heart ‘has got to be junked’: Peta CredlinOctober 14, 2023 | msn.comVoice referendum fallout twist as Deputy Prime Minister Richard Marles says Labor is still committed to the Uluru Statement from the HeartOctober 14, 2023 | msn.comPaddy Twomey can continue his winning ways with King Cuan, while Joseph O’Brien’s Uluru hopes to shine in GowranOctober 13, 2023 | msn.comUluru youth campaigners feeling the love for 'yes' voteOctober 12, 2023 | au.sports.yahoo.comUnexpected advice Albo got in UluruOctober 12, 2023 | msn.comPat Farmer calling on Australians to read Uluru Statement before referendumOctober 12, 2023 | msn.comTwo NSW men found guilty of using oily handprints to damage sacred Uluru cave artOctober 11, 2023 | msn.comAustralia news live: former Liberal MP Pat Farmer reaches Uluru after 14,400km run for the voiceOctober 11, 2023 | msn.com'We need to have change': Dodson in pitch for 'yes'October 11, 2023 | theguardian.comVoice no campaigner claims Uluru statement supporters want ‘their own military’October 10, 2023 | afr.com‘Hell of a journey’: 14,500km Voice run ends at UluruSee More Headlines Receive ULUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ULURU and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today12/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Pharmaceutical Preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ULUR CUSIPN/A CIK1168220 Webwww.uluruinc.com Phone(214) 905-5145Fax214-905-5130Employees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares30,573,000Free Float30,237,000Market Cap$5.35 million OptionableNot Optionable Beta-3.13 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMs. Vaidehi A. Shah (Age 46)Chairman & CEO Comp: $101.88kMr. Anish Vithaldas Shah (Age 56)VP & Director Ms. Oksana V. Tiedt (Age 47)VP of Clinical & International Affairs and Director Mr. P. K Ramachandran (Age 69)Chief Financial Officer Key CompetitorsDMK PharmaceuticalsNASDAQ:DMKBiodexa PharmaceuticalsNASDAQ:BDRXAgile TherapeuticsNASDAQ:AGRXBright Minds BiosciencesNASDAQ:DRUGAptorum GroupNASDAQ:APMView All Competitors ULUR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of ULURU own? Based on aggregate information from My MarketBeat watchlists, some companies that other ULURU investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Jaguar Health (JAGX). How do I buy shares of ULURU? Shares of ULUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:ULUR) was last updated on 12/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ULURU Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.